United Southern Bank - Trust Department’s GSK GSK Stock Holding History

United Southern Bank - Trust Department’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.05M	Buy	+42,481	New	+$2.17M	1.48%	13

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

United Southern Bank - Trust Department's GSK Position: Q3 2026 in Review

United Southern Bank - Trust Department opened a new position in GSK (GSK) in Q3 2026: 42,481 shares worth $2.05M. The stake represents 1.48% of the portfolio and ranks #13 among its holdings.

854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

United Southern Bank - Trust Department held 42,481 shares of GSK worth $2.05M as of Q3 2026.
GSK was a new United Southern Bank - Trust Department position in Q3 2026.
GSK made up 1.48% of United Southern Bank - Trust Department's portfolio in Q3 2026, its #13 holding.
854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on United Southern Bank - Trust Department's 13F filing for Q3 2026, filed 13 Nov 2026.